Today: 16 July 2026
Palantir stock in focus: Pentagon’s Anthropic ban forces Maven AI rewrite

Palantir stock in focus: Pentagon’s Anthropic ban forces Maven AI rewrite

NEW YORK, March 5, 2026, 16:50 (EST)

  • Sources tell us Palantir’s Maven Smart Systems runs on Anthropic’s Claude code.
  • U.S. defense officials told contractors to sever their commercial relationships with Anthropic.
  • Palantir slipped roughly 0.3% on Thursday.

Palantir Technologies Inc is being forced to overhaul its Maven Smart Systems, which serves the Pentagon, after U.S. defense officials ordered contractors to sever commercial deals with AI lab Anthropic, according to two sources. Maven’s workflows currently run on Claude, Anthropic’s AI model, and Palantir is now required to replace it, one person said. Defense Secretary Pete Hegseth has made it clear: “effective immediately” contractors are prohibited from “conduct[ing] any commercial activity” with Anthropic. CEO Alex Karp didn’t mince words, warning that companies who “screw the military” could face “the nationalization of our technology.” https://www.reuters.com/technology/palanti…

Maven Smart Systems, a software platform, assists militaries in analyzing intelligence and backing targeting decisions. For Palantir, this order arrives right as the Pentagon accelerates efforts to inject AI directly into operations—not just as a lab showcase.

Anthropic has been labeled a “supply chain risk” by the Pentagon, a move that could compel government contractors to strip its tools from critical networks, according to a Pentagon official on Thursday. https://www.reuters.com/technology/pentago…

Palantir’s contracts tied to Maven with the Defense Department and other U.S. national security agencies could be worth north of $1 billion, according to one source. Reworking sections of Maven on a different model might drag on for months, that person added, but there’s no firm timeline yet.

Government contracting attorneys say Lockheed Martin and other defense contractors are likely to comply with the Pentagon’s directive to remove Anthropic’s tools from their supply chains. The move highlights how a third-party model, once embedded in mission software, can rapidly turn into a bottleneck.

An industry association representing Nvidia, Amazon, and Apple is urging Hegseth not to invoke emergency “supply chain risk” authority over a procurement disagreement. “We are concerned,” wrote ITI CEO Jason Oxman, who warned that such a move could “undermine the government’s access to the best-in-class products and services.” Oxman added that “removing parts of these solutions … will be a complex endeavor.” https://www.reuters.com/business/retail-co…

Palantir slipped roughly 0.3% to $152.67 on Thursday, hovering in a range from $149.67 up to $156.22, LSEG data showed.

The real trouble hits in the transition. Swapping out Claude on short notice would likely bump up costs for Palantir, slow down updates, or cause hiccups as users get used to the new system; attorneys note the government’s ban might even end up in court.

The Pentagon, Anthropic, and Palantir all declined to say how Maven might be affected or when any changes could roll out. Customers and investors are left to wonder what gets pulled first, and when.

Anthropic spent years trying to break into national security contracts, and by late 2024, it landed a deal to bring its tech into Palantir’s offerings, Reuters reported. But friction emerged with the Pentagon over guardrails—restrictions like bans on domestic surveillance and autonomous weapons—that CEO Dario Amodei was unwilling to relax.

Legal verdict aside, U.S. defense contractors are suddenly having to identify their AI reliance piece by piece. Palantir faces a new challenge now: seeing if Maven keeps functioning as its underlying code gets swapped out.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • AtaiBeckley (NASDAQ: ATAI) Soars 31% After Lilly $3.8B Buyout Bid
    July 16, 2026, 10:45 AM EDT. Shares of AtaiBeckley shot up 31% to $7.04 after Eli Lilly launched a $6.75-a-share cash bid, putting the deal value at up to $3.8 billion. Traders pushed the price $0.29 above the offer, betting on the $2.50 per share CVR tied to drug pipeline goals. About 80% of the CVR hinges on VLS-01, now in Phase 2b as a psychedelic treatment, with another 20% tied to BPL-003, which has FDA breakthrough status. The sale is expected to close in Q3, if it clears shareholder and regulatory hurdles. The market is treating most of the current price as cash and leaving some room for the CVR milestones, which still need regulatory and DEA signoffs.
Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Previous Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets
Next Story

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets

Go toTop